![Safety and efficacy of low-dose isotretinoin in the treatment of moderate to severe acne vulgaris Rao PK, Bhat RM, Nandakishore B, Dandakeri S, Martis J, Kamath GH - Indian J Dermatol Safety and efficacy of low-dose isotretinoin in the treatment of moderate to severe acne vulgaris Rao PK, Bhat RM, Nandakishore B, Dandakeri S, Martis J, Kamath GH - Indian J Dermatol](https://www.e-ijd.org/articles/2014/59/3/images/IndianJDermatol_2014_59_3_316_131455_f9.jpg)
Safety and efficacy of low-dose isotretinoin in the treatment of moderate to severe acne vulgaris Rao PK, Bhat RM, Nandakishore B, Dandakeri S, Martis J, Kamath GH - Indian J Dermatol
![Accutane For Mild Acne | My Experience Taking Low Dose Accutane / Isotretinoin TWICE for Cystic Acne - YouTube Accutane For Mild Acne | My Experience Taking Low Dose Accutane / Isotretinoin TWICE for Cystic Acne - YouTube](https://i.ytimg.com/vi/7tQytvKYvA4/maxresdefault.jpg)
Accutane For Mild Acne | My Experience Taking Low Dose Accutane / Isotretinoin TWICE for Cystic Acne - YouTube
Medical Lady - Low dose of oral accutane should prescribed for acne rosacea 0.25 mg/kg +benoxid+antibiotic | Facebook
![jamika on Twitter: "Reddit threads on a THIRD round of Accutane. Taking a low dose for the rest of my life. What else is there? At the same time, I was also jamika on Twitter: "Reddit threads on a THIRD round of Accutane. Taking a low dose for the rest of my life. What else is there? At the same time, I was also](https://pbs.twimg.com/media/EXnVRkxUYAAar2G.jpg)
jamika on Twitter: "Reddit threads on a THIRD round of Accutane. Taking a low dose for the rest of my life. What else is there? At the same time, I was also
![Systematic review of low‐dose isotretinoin for treatment of acne vulgaris: Focus on indication, dosage, regimen, efficacy, safety, satisfaction, and follow up, based on clinical studies - Sadeghzadeh‐Bazargan - 2021 - Dermatologic Therapy - Systematic review of low‐dose isotretinoin for treatment of acne vulgaris: Focus on indication, dosage, regimen, efficacy, safety, satisfaction, and follow up, based on clinical studies - Sadeghzadeh‐Bazargan - 2021 - Dermatologic Therapy -](https://onlinelibrary.wiley.com/cms/asset/3b175cf9-2193-44d3-8b05-46569661c45f/dth14438-fig-0003-m.jpg)